GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
August 02, 2023 at 10:59 AM EDT
Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.
Photography by Christophe Tomatis